80岁及以上患者的心律失常

Curtis等人（Mon，）在《心律失常》进行了一项综述，评估了年龄特异性管理（药物、导管消融、心脏植入电子设备）。年龄增长（≥80岁）是心律失常的独立风险因素，但此类患者在临床试验中比例不足，导致其管理的证据存在关键缺口。

www.synapsesocial.com/papers/69f2ca21a9949f73c77cb9b9 — DOI: https://doi.org/10.1016/j.jacc.2018.03.019

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Cardiomyocyte apoptosis in hypertensive cardiomyopathy· 2003 · 142 citations
2. Choosing Antithrombotic Therapy for Elderly Patients With Atrial Fibrillation Who Are at Risk for Falls· 1999 · 531 citations
3. Survival in octogenarians receiving implantable defibrillators· 2006 · 80 citations
4. Utilisation of cardiac pacemakers over a 20-year period: Results from a nationwide pacemaker registry· 2016 · 29 citations
5. Age‐Related Prognosis of Syncope Associated with a Preexcitation Syndrome